Category: 2022, No. 01

Application of antisense oligonucleotide in the treatment of inherited retinal dystrophy

Authors: Li Wuyi,  Sui Ruifang DOI: 10.3760/cma.j.cn115989-20210128-00074 Published 2022-01-10 Cite asChin J Exp Ophthalmol, 2022, 40(1): 67-72. Abstract                              [View PDF] [Read Full Text]  Gene therapy is expected to restore the function of genetic material fundamentally and it has become a new […]

NLRP3 inflammasome and its role in age-related macular degeneration

Authors: Chen Lu,  Xie Ping,  Hu Zizhong DOI: 10.3760/cma.j.cn115989-20210922-00527 Published 2022-01-10 Cite as Chin J Exp Ophthalmol, 2022, 40(1): 73-77. Abstract                               [View PDF] [Read Full Text] Age-related macular degeneration (AMD), the leading cause of central vision loss among people aged 50 years […]

Research progress of purinergic signaling in dry age-related macular degeneration

Authors: Hu Yifan,  Sun Xiaodong DOI: 10.3760/cma.j.cn115989-20190717-00316 Published 2022-01-10 Cite asChin J Exp Ophthalmol, 2022, 40(1): 78-82. Abstract                              [View PDF] [Read Full Text] Age-related macular degeneration (AMD) is one of the major causes of visual loss in people over 65 years […]

Application of artificial intelligence in ophthalmic optical coherence tomography

Authors: Duan Kairui,  Zhang Hong DOI: 10.3760/cma.j.cn115989-20191231-00566 Published 2022-01-10 Cite asChin J Exp Ophthalmol, 2022, 40(1): 83-87. Abstract                              [View PDF] [Read Full Text] Artificial intelligence (AI) has become the forefront of research in computer science, which has been widely used in […]

Progress of treatment for large idiopathic macular holes

Authors: Fan Xiaoe,  Ren Xinjun,  Li Xiaorong DOI: 10.3760/cma.j.cn115989-20190129-00039 Published 2022-01-10 Cite asChin J Exp Ophthalmol, 2022, 40(1): 88-92. Abstract                              [View PDF] [Read Full Text] Size of the macular hole (MH) is an important factor affecting the treatment of MH. MH […]

Research progress of metabolomics in diabetic retinopathy

Authors: Zhang Luyuan,  Li Xiaorong DOI: 10.3760/cma.j.cn115989-20201203-00819 Published 2022-01-10 Cite asChin J Exp Ophthalmol, 2022, 40(1): 93-96. Abstract                             [View PDF][Read Full Text]   Diabetic retinopathy (DR) is one of the serious complications of diabetes, and its complex pathogenesis has not been completely clarified […]